drugset

drugset / Trial / NCT07705893

Treating Contact Lens Discomfort With Varenicline Solution Nasal Spray 0.03mg

NCT07705893 ↗

Not yet recruiting 50 enrolled Ocular Aesthetics, LLC dba Ocular Clinical Trials Viatris Inc. · collab

NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to evaluate whether twice-daily use of Tyrvaya improves contact lens comfort in contact lens wearers.

Timeline

Start: 2026-08
Primary completion: 2026-12
Completion: 2027-03

Publications

Background Pucker AD, Tichenor AA. A Review of Contact Lens Dropout. Clin Optom (Auckl). 2020 Jun 25;12:85-94. doi: 10.2147/OPTO.S198637. eCollection 2020.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Varenicline	Small molecule	0.03 mg	Intranasal

Indications